Status: Recruiting
Tocilizumab for Painful Chronic Pancreatitis
This placebo-controlled study will investigate the effect of tocilizumab (an anti-interleukin-6 receptor antibody) on symptom burden, physical functioning, and quality of life in patients with chronic pancreatitis.
Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Soren Schou OlesenUpdated: Jun 25, 2024Locations: 1
Eligibility criteria
Signed informed consent. [+15]
End-stage CP indicated by severe pancreatic atrophy defined as segmented pancrea... [+11]